CMS launches initiative to speed electronic prior authorization adoption
Emily Olsen / healthcaredive - The effort, part of the agency’s ambitious Health Tech Ecosystem, aims to accelerate the industry’s progress before requirements on electronic prior authorization go into effect next year.
AI Summary: CMS launched a national initiative to accelerate adoption of electronic prior authorization, recruiting major health‑IT vendors and health systems to pilot interoperable digital workflows. The program aims to cut paperwork and speed care decisions by automating approvals, though providers warn integration challenges and real‑world impact will take time to materialize.
- AI and automation firms reshaping prior authorization workflows (4)
- CMS' national push to accelerate electronic prior authorization (3)
- Policy fights, insurer delays and patient impact of prior auth (4)
- All Other Stories
AI and automation firms reshaping prior authorization workflows
CMS' national push to accelerate electronic prior authorization
Policy fights, insurer delays and patient impact of prior auth
All Other Stories
US drug overdose deaths fall for 3rd straight year: 5 notes
Kristin Kuchno / beckershospitalreview - An estimated 69,973 Americans died of drug overdoses in the 12-month period ending December 2025, a 13.9% decline from the previous year and the third consecutive year that figure has dropped, according to CDC data published May 13. The decline marks the …
AI Summary: Provisional data show U.S. drug-overdose deaths fell for the third straight year, marking a welcome dip in a long-running crisis. Public-health experts caution the improvement masks shifting drug supplies, regional variation and policy gaps, urging sustained prevention, treatment access and surveillance to avoid backsliding.
CMS pauses hospice, home health Medicare enrollments in fraud crackdown
fiercehealthcare - The Trump administration has issued a six-month moratorium on hospice and home health agencies enrolling in Medicare as part of its efforts to combat fraud.
AI Summary: CMS has suspended new Medicare enrollments for hospice and home health providers nationwide amid a fraud crackdown, pausing approvals while investigators audit suspicious applications and billing patterns. The freeze seeks to protect patients and taxpayer dollars, though it may delay access where new providers were expected to step in — because apparently some providers preferred creative billing over care.
- Nationwide moratorium on hospice and home health enrollments (4)
- Policy and patient access fallout from the freeze (3)
- White House fraud crackdown and enforcement sweep (4)
- All Other Stories
Nationwide moratorium on hospice and home health enrollments
Policy and patient access fallout from the freeze
White House fraud crackdown and enforcement sweep
All Other Stories
Mayo Clinic CEO Gianrico Farrugia stepping down at year's end
fiercehealthcare - Mayo Clinic is looking for a new leader as Gianrico Farrugia, M.D., who has served as president and CEO since 2019, announced he would step down at the end of this year.
AI Summary: Gianrico Farrugia will step down as Mayo Clinic CEO at the end of the year, closing a chapter at one of the nation’s flagship health systems. The move triggers leadership succession planning and board attention amid continuing strategic and operational challenges, as the institution prepares for new stewardship while reassuring staff and patients.
Optum Rx unveils new transparent PBM model
fiercehealthcare - UnitedHealth Group's pharmacy benefit manager, Optum Rx, is making the shift to a more transparent model, the company announced Monday.
AI Summary: Optum Rx unveiled a new pharmacy benefit model that separates drug list prices from PBM fees and adopts clearer pass‑through pricing. Aimed at employers and payers fed up with opaque pharmacy economics, the proposal promises simpler contracts and fee clarity — an attempt to make PBMs boringly accountable and maybe slightly less profitable.
- Industry responses to rising drug costs and PBM models (4)
- Lawmakers and states press PBM vertical-integration reform (4)
- Optum Rx unveils transparent PBM model (4)
- All Other Stories
Industry responses to rising drug costs and PBM models
Lawmakers and states press PBM vertical-integration reform
Optum Rx unveils transparent PBM model
All Other Stories
F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure
Christina Jewett / nytimes - The agency’s top food official will step in as acting commissioner, after Dr. Makary’s tumultuous run as the nation’s top food, drug, tobacco and medical device regulator.
AI Summary: F.D.A. commissioner Marty Makary resigned after weeks of intense scrutiny and internal pressure over leadership and policy choices, following reports he faced possible removal. The agency now confronts leadership turbulence as officials rush to steady regulatory priorities, reassure stakeholders and clean up an exit that leaves unfinished reviews and awkward staff memos.
- Firing reports and buildup to Makary's ouster (4)
- Regulatory ripple effects and agency departures (3)
- Resignation announced and immediate leadership vacuum (5)
- All Other Stories
Firing reports and buildup to Makary's ouster
Regulatory ripple effects and agency departures
Resignation announced and immediate leadership vacuum
All Other Stories
PCOS has been officially renamed PMOS, and it’s a momentous move
newscientist - PCOS will now be known as PMOS (polyendocrine metabolic ovarian syndrome), and for Alice Klein, who has the conditon, it's been a long time coming
AI Summary: Medical experts have rebranded polycystic ovary syndrome as "polyendocrine metabolic ovarian syndrome" (PMOS) to better reflect its metabolic and endocrine drivers and improve diagnosis and treatment for about 170 million affected women worldwide. The change follows years of debate over an inaccurate name and aims to reduce misdiagnosis and guide more targeted care—because calling it something sensible might actually help.
Healthcare bankruptcies increased 33% in Q1: 6 things to know
Andrew Cass / beckershospitalreview - Healthcare Chapter 11 bankruptcy filings rose to 12 cases in the first quarter of 2026, up from 9 cases in the fourth quarter of 2025, according to an April report by Gibbins Advisors. The report analyzed Chapter 11 bankruptcy filings with liabilities of …
AI Summary: A new report finds healthcare bankruptcies rose 33% in the first quarter, underscoring mounting financial pressure across providers from squeezed margins, rising expenses and a tricky reimbursement environment. The surge raises concerns about patient access, consolidation and creditor fallout, and suggests policymakers and executives may need to stop pinching pennies and start fixing structural problems.
- Budgeting, Labor and Management Fixes Under Strain (5)
- Closures, Downgrades and State Rescue Responses (4)
- Q1 Bankruptcy Surge: Numbers and Sector Breakdown (3)
- All Other Stories
Budgeting, Labor and Management Fixes Under Strain
Closures, Downgrades and State Rescue Responses
Q1 Bankruptcy Surge: Numbers and Sector Breakdown
All Other Stories
A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved Therapy
Frank Vinluan / medcitynews - Partner Therapeutics’ Bizengri is now FDA approved for treating advanced cases of cholangiocarcinoma driven by NRG1 gene fusions. Partner acquired U.S. rights to this bispecific antibody from Merus in 2024. The post A Cancer Driven by Ultra-Rare Mutation …
AI Summary: The FDA approved zenocutuzumab‑zbco for NRG1‑fusion–positive cholangiocarcinoma, delivering the first cleared therapy for cancers driven by this ultra‑rare genomic alteration. Trial data showed meaningful responses in heavily pretreated patients, prompting regulators to greenlight a precision option that offers targeted benefit where none existed — a small‑population win for genomic oncology.
With Commissioner Under Pressure, F.D.A. Opens Door to Flavored Vapes
Christina Jewett / nytimes - Though illicit e-cigarettes have flooded in from China, the new policy could allow major tobacco companies to sell from prime shelf space at thousands of stores.
AI Summary: Facing mounting pressure, the FDA has signaled authorization of fruit‑flavored vaping products for adults, a regulatory shift framed as adult access and harm reduction. Public‑health experts warn the move risks increasing youth appeal and reignites debate over flavors, enforcement, and whether potential population‑level tradeoffs were adequately considered.
500-year-old gold dental bridge is earliest known oral care of its kind in Scotland — and it likely held a fake tooth
livescience - Archaeologists discovered the 20-karat-gold dental wire in the lower jaw of a middle-aged man who lived around 500 years ago in Scotland.
AI Summary: Archaeologists uncovered what appears to be the earliest known gold dental bridge in Scotland, dating roughly four to five centuries ago and likely fitted with a faux tooth. The discovery sheds light on historic dental practice, craftsmanship and status signaling—proof that vanity and dental innovation are nothing new.
1K steps daily after surgery can cut readmissions by 16%: 3 study notes
Mariah Taylor / beckershospitalreview - Each additional 1,000 steps per day a patient walks after surgery is linked to 18% lower odds of complications, 16% lower readmission rates and 6% shorter hospital stays, researchers found. The study, conducted by researchers at Columbus-based Ohio State …
AI Summary: A simple prescription — roughly 1,000 steps per day after surgery — was linked to a 16% reduction in readmissions in recent studies. Researchers suggest wearable step tracking as an inexpensive, scalable recovery aid that encourages mobility, reduces complications, and nudges postoperative care toward behaviourally realistic, low‑tech interventions that actually work.
Health advice is all over social media. Here's how to vet claims
medicalxpress - Health and wellness advice is available in abundance on social media—from trendy to informative to straight-up disinformation—and you're far from alone in seeing it.
AI Summary: Social media is awash with health advice, much of it anecdote masquerading as evidence. Report outlines practical steps to separate useful guidance from nonsense: check original sources, prefer peer‑reviewed studies and guidelines, question sensational claims, and consult clinicians before acting. Because no, a viral post is not a clinical trial.
A new Medicare option for weight loss drugs is coming: Here's what to know
Jackie Fortiér / npr - Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work.
AI Summary: Medicare is introducing a new option to expand access to weight‑loss medications for older Americans, outlining eligibility, coverage mechanics and likely impacts on beneficiaries and budgets. The guidance aims to help clinicians and patients navigate coverage decisions and prepares stakeholders for shifts in prescribing patterns and costs as demand for GLP‑1 class drugs remains high.
- Competition, dosing and long-term weight strategies (4)
- Efficacy and safety of GLP‑1s in older adults (3)
- Medicare expansion and coverage landscape (3)
- All Other Stories
Competition, dosing and long-term weight strategies
Efficacy and safety of GLP‑1s in older adults
Medicare expansion and coverage landscape
All Other Stories
The peptide problem: Hype is outrunning the evidence
medicalxpress - Health Canada recently warned Canadians not to buy or inject unauthorized peptide drugs sold online, naming products that include BPC-157, CJC-1295, ipamorelin, TB-500 and retatrutide.
AI Summary: The booming market for peptide therapies and supplements is racing past the science. Researchers report limited clinical evidence, unclear long-term safety, and weak regulatory oversight, while consumer demand and marketing hype surge. Clinicians urge caution: biological plausibility isn’t the same as proven benefit, and enthusiasm should not substitute for rigorous trials.
FDA approves blood test to guide breast cancer therapy
Ella Jeffries / beckershospitalreview - The FDA has approved a companion diagnostic from Guardant Health to identify patients eligible for treatment with a targeted therapy developed by Pfizer and Arvinas. The blood-based test detects ESR1 mutations in patients with estrogen receptor-positive, …
AI Summary: The FDA approved a blood‑based test to help guide breast cancer treatment selection, authorizing a diagnostic that identifies patients more likely to benefit from specific therapies. The move could reduce unnecessary treatments and sharpen precision oncology, though broad clinical adoption will depend on further validation, payer coverage and clinician trust.
- ESMO Breast highlights and expert commentary (4)
- FDA clearances reshape diagnostics and therapies (3)
- Liquid biopsy, mutations and treatment resistance (4)
- All Other Stories
ESMO Breast highlights and expert commentary
FDA clearances reshape diagnostics and therapies
Liquid biopsy, mutations and treatment resistance
All Other Stories
Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
fiercehealthcare - The deal, expected to close later this year, is another attempt from the major rural nonprofit system to enter the Minneapolis market. To do so, it plans a $600 million investment into two-hospital North Memorial Health that will help stabilize one financ…
AI Summary: Sanford Health announced a plan to integrate Minnesota-area North Memorial Health with a $600 million investment, creating a combined system aimed at expanding services, streamlining care and gaining scale. The transaction is part of a broader wave of regional healthcare consolidation as systems chase efficiency and market presence.
Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
fiercehealthcare - The deal would bring the 40-year-old, publicly traded company under a growth-oriented investment firm with a prior background in healthcare staffing.
AI Summary: Staffing firm Cross Country Healthcare agreed to be taken private in a $437 million deal by private equity buyer Knox Lane, ending its public-company chapter. The acquisition positions the firm for strategic repositioning and could reverberate across hospital staffing markets as investors consolidate workforce services.
RFK Jr. launches plan to curb antidepressant 'overprescription'
medicalxpress - A new federal initiative aims to curb "overprescribing" of psychiatric medications while emphasizing holistic care.
AI Summary: Robert F. Kennedy Jr. launched a campaign aimed at reducing antidepressant prescribing and helping people taper long-term use, combining policy proposals and public outreach. The initiative challenges current prescribing norms and has provoked debate between advocates for reducing medication dependence and clinicians cautious about abrupt shifts in psychiatric care.
National study examines genetic testing to inform follow-up care for cancer survivors
medicalxpress - Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are just as likely as those…
AI Summary: A national study has been launched to assess whether genetic testing can refine follow-up care for cancer survivors, tailoring surveillance to individual risk and potentially reducing unnecessary tests. The large-scale effort seeks to integrate genomic data into survivorship plans to better predict late effects and allocate resources to those most likely to benefit.
- Building survivorship standards, care and advocacy (4)
- Conferences, research and personalized cancer survivorship insights (4)
- National genetic-testing study and genomic implications for survivors (4)
- All Other Stories